A Study of Ninlaro in Real World Clinical Practice in China

Active, not recruitingOBSERVATIONAL
Enrollment

482

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

March 30, 2026

Study Completion Date

March 30, 2026

Conditions
Multiple MyelomaNeoplasms, Plasma Cell
Trial Locations (28)

100020

Beijing Chao-yang Hospital,Capital Medical University, Beijing

100034

Peking University First Hospital, Beijing

100035

Beijing Jishuitan Hospital, Beijing

100043

Beijing Chao-yang Hospital,Capital Medical University(Shijingshan), Beijing

100191

Peking University Third Hospital, Beijing

100730

Peking Union Medical College Hospital, Beijing

110001

The First Hospital of China Medical University, Shenyang

116011

The First Affiliated Hospital of Dalian Medical University, Dalian

130021

The First Bethune Hospital of Jilin University, Changchun

150081

Harbin Medical University Cancer Hospital, Harbin

200070

Zhabei Central Hospital, Jing'an District, Shanghai, Shanghai

214023

Wuxi People's Hospital, Wuxi

215006

The First Affiliated Hospital of Soochow University, Suzhou

215100

Soochow Hongci Blood Disease Hospital, Suzhou

230031

Anhui Cancer Hospital, Hefei

271099

Tai'an Central Hospital, Tai’an

272007

Affiliated Hospital of Jining Medical College, Jining

300052

Tianjin Medical University General Hospital, Tianjin

312099

Shaoxing People's Hospital, Shaoxing

318020

Taizhou First People's Hospital, Taizhou

450003

Henan Cancer Hospital, Zhengzhou

510120

Sun Yat-Sen Memorial Hospital, Guangzhou

510280

Zhujiang Hospital, Southern Medical University, Guangzhou

510630

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

570311

Hainan General Hospital, Haikou

610041

West China Hospital, Sichuan University, Chengdu

037046

Datong Third People's Hospital, Datong

030012

Shanxi Provincial People's Hospital, Taiyuan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT04328662 - A Study of Ninlaro in Real World Clinical Practice in China | Biotech Hunter | Biotech Hunter